Expanded Total Assets by 33% in 2013 Reflecting $700 Million in
Acquisitions
On Track for Sustained Growth in 2014
BIRMINGHAM, Ala.--(BUSINESS WIRE)--Feb. 6, 2014--
Medical Properties Trust, Inc. (the “Company” and “MPT”) (NYSE: MPW)
today announced financial and operating results for the quarter and year
ended December 31, 2013. The results of 2013 continued the extraordinary
improvements made during 2012 in investment growth, revenue and
operating results and per share funds from operations. Highlights of
these improvements include:
-
Normalized Funds from Operations (“FFO”) per diluted share grew to
$0.96, up 7% year-over-year in 2013 and 35% since 2011;
-
Earned $243 million in 2013 revenues, up 22% year-over-year in 2013
and 79% since 2011;
-
Completed acquisitions totaling approximately $700 million in 2013,
and expanded gross asset base by 33% year-over-year and approximately
80% since 2011;
-
Achieved fourth quarter normalized FFO per diluted share of $0.26,
before certain items; resulting in reported $0.24 per share;
-
Completed the €184 million acquisition of 11 German facilities in a
sale / leaseback transaction valued at approximately $250 million
(including transfer taxes of $12 million) to further expand geographic
diversity of asset portfolio;
-
Completed a €200 million euro-denominated (approximately $275 million)
long-term fixed rate debt transaction at an annual coupon of 5.75%;
-
During fourth quarter, completed $45 million aggregate investments in
two acute care hospitals with two operators, and commenced development
of 10 (five in 2014) additional free-standing emergency facilities;
-
Sold an inpatient rehabilitation facility to a third party real estate
owner – facilitated by the operator – for $14 million, which resulted
in a 280 basis point cap rate compression and an unlevered internal
rate of return of 14.1%;
-
Increased the annualized cash dividend by 5% to $0.21 per share with
the fourth quarter dividend payment.
Included in the financial tables accompanying this press release is
information about the Company’s assets and liabilities, net income and
reconciliations of net income to FFO and AFFO, all on a comparable basis
to 2012 periods.
“This has been another great year for MPT as we built upon our track
record for driving growth and building shareholder value,” said Edward
K. Aldag, Jr., Chairman, President and CEO of Medical Properties Trust.
“In 2013 we leveraged our expertise in healthcare real estate, finance
and operations to continue executing on our strategy to diversify our
portfolio of hospital-only investments. Our standing as the only U.S.
healthcare REIT focused exclusively on funding hospitals allowed us to
deliver 7% FFO per share growth while expanding our revenue by 22% and
our gross asset base by 33% during 2013. Since 2011, we have grown FFO
per share by 35%, revenue by 79% and our gross assets by nearly 80%.
“We entered 2014 with strong momentum,” continued Aldag. “Late in the
fourth quarter of 2013, we completed the acquisition of our first
overseas transaction, which topped off $700 million in acquisitions
during 2013. Looking ahead, we intend to continue to make smart
acquisitions, build upon our growth trajectory and deliver the results
our shareholders have come to expect. We have a strong acquisition
pipeline and a demonstrated ability to drive consistent FFO growth that
we believe will allow us to create shareholder value in 2014 and beyond.”
OPERATING RESULTS
Normalized FFO for the quarter increased 12% to $38.1 million compared
with fourth quarter of 2012. Normalized FFO per share was $0.24. Annual
and fourth quarter normalized FFO was impacted by two timing issues that
aggregated approximately $3.5 million, without which normalized FFO
would have approximated $41.6 million and $0.26 per diluted share. Early
in the fourth quarter, MPT prefunded the acquisition of the German
rehabilitation portfolio; the interest expense on non-invested proceeds
and the rent not collected as a result of a 30 day delay in anticipated
closing approximated $2.6 million. In addition, as a result of MPT’s
three-year 43% total return to shareholders, $0.9 million of performance
share awards were accelerated from future periods, as previously
estimated, into 2013. There was no impact on total expense or the number
of shares originally awarded in 2011 and 2012.
For the twelve months ended December 31, 2013, normalized FFO increased
23% to $147.2 million from $119.4 million in 2012. On a per diluted
share basis, normalized FFO increased 7% for that same period to $0.96
per diluted share from $0.90 per diluted share for 2012. These results
were also affected by the timing issues described above.
Net income for the fourth quarter of 2013, before gains on property
sales and the previously announced recording of transfer taxes
associated with the German portfolio acquisition, was $24.2 million (or
$0.15 per diluted share) compared with net income of $19.5 million (or
$0.14 per diluted share) in the fourth quarter of 2012 before gains on
property sales. The approximate $250 million investment in the German
rehabilitation portfolio includes transfer taxes aggregating
approximately $12 million. Although this portion of the investment is
treated as an acquisition expense for accounting purposes, it is
included in the lease base on which rental payments are calculated and
paid.
Net income under generally accepted accounting principles for the twelve
months ended December 31, 2013 grew 8% to $97.0 million from $90.0
million in 2012.
PORTFOLIO UPDATE AND FUTURE OUTLOOK
During the last two years, MPT has made immediately accretive
investments exceeding $1.5 billion, an average compound annual growth
rate of 34%, adding approximately $160 million in new annualized
revenue. During the same period, the Company has established diverse
sources of low-cost capital to fund these and future acquisitions of
high-yielding hospital real estate.
Based solely on the already completed acquisitions and facilities under
development, per share normalized FFO has grown 35% in the last two
years and is expected to grow further by up to 14% to between
approximately $1.08 and $1.12 in 2014. In addition, MPT expects to
invest at least $500 million of similarly accretive acquisitions and
developments in 2014, the FFO from which is not included in the 2014
estimate.
These estimates do not include the effects, if any, of real estate
operating costs, litigation costs, debt refinancing costs, acquisition
costs, interest rate hedging activities, foreign currency impacts,
write-offs of straight-line rent or other non-recurring or unplanned
transactions. These estimates will change if the Company acquires assets
totaling more or less than its expectations, the timing of acquisitions
varies from expectations, capitalization rates vary from expectations,
market interest rates change, debt is refinanced, new shares are issued,
additional debt is incurred, assets are sold, other operating expenses
vary, income from investments in tenant operations vary from
expectations, or existing leases do not perform in accordance with their
terms.
In the fourth quarter of 2013, the Company invested in 13 facilities,
divested one facility and opened three additional development projects.
-
On November 30, the Company completed the previously announced
acquisition of an 11 property rehabilitation hospital portfolio in
Germany operated by RHM Klinik- und Altenheimbetriebe GmbH & Co. KG
(“RHM”) for €184.0 million (approximately $250 million);
-
On December 12, MPT acquired the real estate of the 155-bed Dallas
Medical Center in North Dallas for $25 million, which is operated by
Prime Healthcare Services;
-
On December 31, the Company provided a $20 million mortgage financing
to Alecto Healthcare Services for the 204-bed Olympia Medical Center,
which is located just east of Beverly Hills in the Mid-Wilshire
district of Los Angeles;
-
On November 27, MPT sold a 65-bed inpatient rehabilitation facility in
San Antonio for $14 million for a $5.6 million gain, which equates to
a 14.1% unlevered internal rate of return and a 280 basis point cap
rate improvement for the Company;
-
MPT also completed three development projects in the quarter and has
commenced 10 other development projects with First Choice ER in the
fourth quarter and 2014.
On December 31, 2013, the Company had total real estate and related
investments of approximately $2.8 billion comprised of 107 healthcare
properties in 25 states and in Germany. The properties are leased or
loaned to 27 different hospital operating companies.
CONFERENCE CALL AND WEBCAST
The Company has scheduled a conference call and webcast for Thursday,
February 6, 2014, at 11:00 a.m. Eastern Time to present the Company’s
financial and operating results for the quarter ended December 31, 2013.
The dial-in telephone numbers for the conference call are 866-515-2912
(U.S.) and 617-399-5126 (International); using passcode 17141102. The
conference call will also be available via webcast in the Investor
Relations’ section of the Company’s website, www.medicalpropertiestrust.com.
A telephone and webcast replay of the call will be available from
shortly after the completion of the call through February 20, 2014.
Telephone numbers for the replay are 888-286-8010 and 617-801-6888 for
U.S. and International callers, respectively. The replay passcode is
92142385.
The Company’s supplemental information package for the current period
will also be available on the Company’s website under the “Investor
Relations” section.
About Medical Properties Trust, Inc.
Medical Properties Trust, Inc. is a Birmingham, Alabama based
self-advised real estate investment trust formed to capitalize on the
changing trends in healthcare delivery by acquiring and developing
net-leased healthcare facilities. These facilities include inpatient
rehabilitation hospitals, long-term acute care hospitals, regional acute
care hospitals, ambulatory surgery centers and other single-discipline
healthcare facilities. For more information, please visit the Company’s
website at www.medicalpropertiestrust.com.
The statements in this press release that are forward looking are
based on current expectations and actual results or future events may
differ materially. Words such as "expects," "believes," "anticipates,"
"intends," "will," "should” and variations of such words and similar
expressions are intended to identify such forward-looking statements.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results of the
Company or future events to differ materially from those expressed in or
underlying such forward-looking statements, including without
limitation: the capacity of the Company’s tenants to meet the terms of
their agreements; Normalized FFO per share; expected payout ratio, the
amount of acquisitions of healthcare real estate, if any; capital
markets conditions, the repayment of debt arrangements; statements
concerning the additional income to the Company as a result of ownership
interests in certain hospital operations and the timing of such income;
the restructuring of the Company’s investments in non-revenue
producing properties; the payment of future dividends, if any;
completion of additional debt arrangement, and additional investments;
national and economic, business, real estate and other market
conditions; the competitive environment in which the Company operates;
the execution of the Company's business plan; financing risks; the
Company's ability to maintain its status as a REIT for federal income
tax purposes; acquisition and development risks; potential environmental
and other liabilities; and other factors affecting the real estate
industry generally or healthcare real estate in particular. For further
discussion of the factors that could affect outcomes, please refer to
the "Risk factors" section of the Company's Annual Report on Form 10-K
for the year ended December 31, 2012, and as updated by the Company’s
subsequently filed Quarterly Reports on Form 10-Q and other SEC filings.
Except as otherwise required by the federal securities laws, the Company
undertakes no obligation to update the information in this press release.
|
|
|
|
|
|
|
|
|
|
|
|
|
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
|
|
|
|
|
|
|
|
Consolidated Balance Sheets
|
|
|
|
|
|
|
|
|
|
December 31, 2013
|
|
December 31, 2012
|
|
Assets
|
|
(Unaudited)
|
|
(A)
|
|
Real estate assets
|
|
|
|
|
|
Land, buildings and improvements, and intangible lease assets
|
|
$
|
1,823,683,129
|
|
|
$
|
1,212,901,420
|
|
|
Construction in progress and other
|
|
|
41,771,499
|
|
|
|
38,338,985
|
|
|
Real estate held for sale
|
|
|
-
|
|
|
|
25,537,486
|
|
|
Net investment in direct financing leases
|
|
|
431,024,228
|
|
|
|
314,411,549
|
|
|
Mortgage loans
|
|
|
388,650,000
|
|
|
|
368,650,000
|
|
|
Gross investment in real estate assets
|
|
|
2,685,128,856
|
|
|
|
1,959,839,440
|
|
|
Accumulated depreciation and amortization
|
|
|
(159,776,091
|
)
|
|
|
(122,796,563
|
)
|
|
Net investment in real estate assets
|
|
|
2,525,352,765
|
|
|
|
1,837,042,877
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
45,979,648
|
|
|
|
37,311,207
|
|
|
Interest and rent receivable
|
|
|
58,499,609
|
|
|
|
45,288,845
|
|
|
Straight-line rent receivable
|
|
|
45,828,697
|
|
|
|
35,859,703
|
|
|
Other assets
|
|
|
228,909,650
|
|
|
|
223,383,020
|
|
|
Total Assets
|
|
$
|
2,904,570,369
|
|
|
$
|
2,178,885,652
|
|
|
|
|
|
|
|
|
Liabilities and Equity
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
Debt, net
|
|
$
|
1,421,680,749
|
|
|
$
|
1,025,159,854
|
|
|
Accounts payable and accrued expenses
|
|
|
94,311,177
|
|
|
|
65,960,792
|
|
|
Deferred revenue
|
|
|
23,786,819
|
|
|
|
20,609,467
|
|
|
Lease deposits and other obligations to tenants
|
|
|
20,583,283
|
|
|
|
17,341,694
|
|
|
Total liabilities
|
|
|
1,560,362,028
|
|
|
|
1,129,071,807
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
Preferred stock, $0.001 par value. Authorized 10,000,000 shares;
no shares outstanding
|
|
|
-
|
|
|
|
-
|
|
|
Common stock, $0.001 par value. Authorized 250,000,000 shares;
issued and outstanding - 161,309,725 shares at December 31, 2013
and 136,335,427 shares at December 31, 2012
|
|
|
161,310
|
|
|
|
136,336
|
|
|
Additional paid in capital
|
|
|
1,618,054,133
|
|
|
|
1,295,916,192
|
|
|
Distributions in excess of net income
|
|
|
(264,804,113
|
)
|
|
|
(233,494,130
|
)
|
|
Accumulated other comprehensive income (loss)
|
|
|
(8,940,646
|
)
|
|
|
(12,482,210
|
)
|
|
Treasury shares, at cost
|
|
|
(262,343
|
)
|
|
|
(262,343
|
)
|
|
Total Equity
|
|
|
1,344,208,341
|
|
|
|
1,049,813,845
|
|
|
|
|
|
|
|
|
Total Liabilities and Equity
|
|
$
|
2,904,570,369
|
|
|
$
|
2,178,885,652
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(A) Financials have been derived from the prior year audited
financials; however, we have reclassed the real estate (including
accumulated depreciation) of certain properties sold in 2013 to
Real Estate Held for Sale.
|
|
|
|
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
|
|
|
|
Consolidated Statements of Income
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
|
For the Twelve Months Ended
|
|
|
|
December 31, 2013
|
|
December 31, 2012
|
|
December 31, 2013
|
|
December 31, 2012
|
|
|
|
|
|
(A)
|
|
|
|
(A)
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
Rent billed
|
|
$
|
38,520,039
|
|
|
$
|
30,192,222
|
|
|
$
|
132,578,216
|
|
|
$
|
119,882,517
|
|
|
Straight-line rent
|
|
|
2,474,148
|
|
|
|
2,535,667
|
|
|
|
10,705,792
|
|
|
|
7,911,656
|
|
|
Income from direct financing leases
|
|
|
11,545,956
|
|
|
|
8,748,999
|
|
|
|
40,830,388
|
|
|
|
21,728,141
|
|
|
Interest and fee income
|
|
|
15,139,342
|
|
|
|
15,120,443
|
|
|
|
58,409,167
|
|
|
|
48,602,700
|
|
|
Total revenues
|
|
|
67,679,485
|
|
|
|
56,597,331
|
|
|
|
242,523,563
|
|
|
|
198,125,014
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
Real estate depreciation and amortization
|
|
|
11,151,338
|
|
|
|
8,212,451
|
|
|
|
36,977,724
|
|
|
|
32,814,417
|
|
|
Property-related
|
|
|
934,118
|
|
|
|
453,858
|
|
|
|
2,450,521
|
|
|
|
1,477,242
|
|
|
Acquisition expenses (includes $12.0 million in transfer taxes in
2013)
|
|
|
13,036,440
|
|
|
|
1,305,731
|
|
|
|
19,493,657
|
|
|
|
5,420,427
|
|
|
General and administrative
|
|
|
8,901,727
|
|
|
|
7,306,977
|
|
|
|
30,063,409
|
|
|
|
28,562,272
|
|
|
Total operating expenses
|
|
|
34,023,623
|
|
|
|
17,279,017
|
|
|
|
88,985,311
|
|
|
|
68,274,358
|
|
|
Operating income
|
|
|
33,655,862
|
|
|
|
39,318,314
|
|
|
|
153,538,252
|
|
|
|
129,850,656
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and other income (expense)
|
|
|
(19,881,506
|
)
|
|
|
(16,120,991
|
)
|
|
|
(63,511,002
|
)
|
|
|
(56,961,855
|
)
|
|
Income tax (expense) benefit
|
|
|
(464,219
|
)
|
|
|
66,810
|
|
|
|
(725,707
|
)
|
|
|
(19,183
|
)
|
|
Income from continuing operations
|
|
|
13,310,137
|
|
|
|
23,264,133
|
|
|
|
89,301,543
|
|
|
|
72,869,618
|
|
|
Income from discontinued operations
|
|
|
4,587,686
|
|
|
|
5,339,257
|
|
|
|
7,913,867
|
|
|
|
17,207,329
|
|
|
Net income
|
|
|
17,897,823
|
|
|
|
28,603,390
|
|
|
|
97,215,410
|
|
|
|
90,076,947
|
|
|
Net income attributable to non-controlling interests
|
|
|
(59,083
|
)
|
|
|
(47,430
|
)
|
|
|
(224,300
|
)
|
|
|
(177,252
|
)
|
|
Net income attributable to MPT common stockholders
|
|
$
|
17,838,740
|
|
|
$
|
28,555,960
|
|
|
$
|
96,991,110
|
|
|
$
|
89,899,695
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share - basic:
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
0.08
|
|
|
$
|
0.17
|
|
|
$
|
0.59
|
|
|
$
|
0.54
|
|
|
Income from discontinued operations
|
|
|
0.03
|
|
|
|
0.04
|
|
|
|
0.05
|
|
|
|
0.13
|
|
|
Net income attributable to MPT common stockholders
|
|
$
|
0.11
|
|
|
$
|
0.21
|
|
|
$
|
0.64
|
|
|
$
|
0.67
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share - diluted:
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
0.08
|
|
|
$
|
0.17
|
|
|
$
|
0.58
|
|
|
$
|
0.54
|
|
|
Income from discontinued operations
|
|
|
0.03
|
|
|
|
0.04
|
|
|
|
0.05
|
|
|
|
0.13
|
|
|
Net income attributable to MPT common stockholders
|
|
$
|
0.11
|
|
|
$
|
0.21
|
|
|
$
|
0.63
|
|
|
$
|
0.67
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends declared per common share
|
|
$
|
0.21
|
|
|
$
|
0.20
|
|
|
$
|
0.81
|
|
|
$
|
0.80
|
|
|
|
|
|
|
|
.
|
|
|
|
|
|
.
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding - basic
|
|
|
161,142,567
|
|
|
|
134,922,510
|
|
|
|
151,439,002
|
|
|
|
132,331,091
|
|
|
Weighted average shares outstanding - diluted
|
|
|
161,839,544
|
|
|
|
134,930,189
|
|
|
|
152,597,666
|
|
|
|
132,333,157
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(A) Financials have been restated to reclass the
operating results of certain properties sold in 2013 to
discontinued operations.
|
|
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES
|
|
Reconciliation of Net Income to Funds From Operations
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
|
For the Twelve Months Ended
|
|
|
|
December 31, 2013
|
|
December 31, 2012
|
|
December 31, 2013
|
|
December 31, 2012
|
|
|
|
|
|
(A)
|
|
|
|
(A)
|
|
FFO information:
|
|
|
|
|
|
|
|
|
|
Net income attributable to MPT common stockholders
|
|
$
|
17,838,740
|
|
|
$
|
28,555,960
|
|
|
$
|
96,991,110
|
|
|
$
|
89,899,695
|
|
|
Participating securities' share in earnings
|
|
|
(190,142
|
)
|
|
|
(171,473
|
)
|
|
|
(728,533
|
)
|
|
|
(886,374
|
)
|
|
Net income, less participating securities' share in earnings
|
|
$
|
17,648,598
|
|
|
$
|
28,384,487
|
|
|
$
|
96,262,577
|
|
|
$
|
89,013,321
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization:
|
|
|
|
|
|
|
|
|
|
Continuing operations
|
|
|
11,151,338
|
|
|
|
8,212,451
|
|
|
|
36,977,724
|
|
|
|
32,814,417
|
|
|
Discontinued operations
|
|
|
380,966
|
|
|
|
230,140
|
|
|
|
708,422
|
|
|
|
2,041,268
|
|
|
Gain on sale of real estate
|
|
|
(5,605,087
|
)
|
|
|
(9,089,008
|
)
|
|
|
(7,659,316
|
)
|
|
|
(16,369,188
|
)
|
|
Funds from operations
|
|
$
|
23,575,815
|
|
|
$
|
27,738,070
|
|
|
$
|
126,289,407
|
|
|
$
|
107,499,818
|
|
|
|
|
|
|
|
|
|
|
|
|
Write-off straight line rent
|
|
|
1,457,235
|
|
|
|
4,816,433
|
|
|
|
1,457,235
|
|
|
|
6,456,272
|
|
|
Acquisition costs (includes $12.0 million in transfer taxes in 2013)
|
|
|
13,036,440
|
|
|
|
1,305,731
|
|
|
|
19,493,657
|
|
|
|
5,420,427
|
|
|
Normalized funds from operations
|
|
$
|
38,069,490
|
|
|
$
|
33,860,234
|
|
|
$
|
147,240,299
|
|
|
$
|
119,376,517
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based compensation
|
|
|
2,812,906
|
|
|
|
2,207,235
|
|
|
|
8,832,006
|
|
|
|
7,637,420
|
|
|
Debt costs amortization
|
|
|
934,383
|
|
|
|
880,777
|
|
|
|
3,558,506
|
|
|
|
3,458,797
|
|
|
Additional rent received in advance (B)
|
|
|
(300,000
|
)
|
|
|
(300,000
|
)
|
|
|
(1,200,000
|
)
|
|
|
(1,200,000
|
)
|
|
Straight-line rent revenue and other
|
|
|
(4,673,544
|
)
|
|
|
(3,907,388
|
)
|
|
|
(17,039,339
|
)
|
|
|
(11,696,822
|
)
|
|
Adjusted funds from operations
|
|
$
|
36,843,235
|
|
|
$
|
32,740,858
|
|
|
$
|
141,391,472
|
|
|
$
|
117,575,912
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Per diluted share data:
|
|
|
|
|
|
|
|
|
|
Net income, less participating securities' share in earnings
|
|
$
|
0.11
|
|
|
$
|
0.21
|
|
|
$
|
0.63
|
|
|
$
|
0.67
|
|
|
Depreciation and amortization:
|
|
|
|
|
|
|
|
|
|
Continuing operations
|
|
|
0.07
|
|
|
|
0.06
|
|
|
|
0.24
|
|
|
|
0.25
|
|
|
Discontinued operations
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
0.01
|
|
|
Gain on sale of real estate
|
|
|
(0.03
|
)
|
|
|
(0.06
|
)
|
|
|
(0.04
|
)
|
|
|
(0.12
|
)
|
|
Funds from operations
|
|
$
|
0.15
|
|
|
$
|
0.21
|
|
|
$
|
0.83
|
|
|
$
|
0.81
|
|
|
|
|
|
|
|
|
|
|
|
|
Write-off straight line rent
|
|
|
0.01
|
|
|
|
0.03
|
|
|
|
0.01
|
|
|
|
0.05
|
|
|
Acquisition costs
|
|
|
0.08
|
|
|
|
0.01
|
|
|
|
0.12
|
|
|
|
0.04
|
|
|
Normalized funds from operations
|
|
$
|
0.24
|
|
|
$
|
0.25
|
|
|
$
|
0.96
|
|
|
$
|
0.90
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based compensation
|
|
|
0.02
|
|
|
|
0.02
|
|
|
|
0.06
|
|
|
|
0.06
|
|
|
Debt costs amortization
|
|
|
0.01
|
|
|
|
0.01
|
|
|
|
0.02
|
|
|
|
0.03
|
|
|
Additional rent received in advance (B)
|
|
|
(0.01
|
)
|
|
|
(0.01
|
)
|
|
|
(0.01
|
)
|
|
|
(0.01
|
)
|
|
Straight-line rent revenue and other
|
|
|
(0.03
|
)
|
|
|
(0.03
|
)
|
|
|
(0.10
|
)
|
|
|
(0.09
|
)
|
|
Adjusted funds from operations
|
|
$
|
0.23
|
|
|
$
|
0.24
|
|
|
$
|
0.93
|
|
|
$
|
0.89
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(A) Financials have been restated to reclass the
operating results of certain properties sold in 2013 to
discontinued operations.
|
|
|
|
|
|
|
|
|
|
|
|
(B) Represents additional rent from one tenant in
advance of when we can recognize as revenue for accounting
purposes.
|
|
This additional rent is being recorded to revenue on a straight-line
basis over the lease life.
|
|
Investors and analysts following the real estate industry utilize
funds from operations, or FFO, as a supplemental performance
measure. FFO, reflecting the assumption that real estate asset
values rise or fall with market conditions, principally adjusts for
the effects of GAAP depreciation and amortization of real estate
assets, which assumes that the value of real estate diminishes
predictably over time. We compute FFO in accordance with the
definition provided by the National Association of Real Estate
Investment Trusts, or NAREIT, which represents net income (loss)
(computed in accordance with GAAP), excluding gains (losses) on
sales of real estate and impairment charges on real estate assets,
plus real estate depreciation and amortization and after adjustments
for unconsolidated partnerships and joint ventures.
|
|
|
|
In addition to presenting FFO in accordance with the NAREIT
definition, we also disclose normalized FFO,which adjusts FFO for
items that relate to unanticipated or non-core events or activities
or accounting changes that, if not noted, would make comparison to
prior period results and market expectations less meaningful to
investors and analysts. We believe that the use of FFO, combined
with the required GAAP presentations, improves the understanding of
our operating results among investors and the use of normalized FFO
makes comparisons of our operating results with prior periods and
other companies more meaningful. While FFO and normalized FFO are
relevant and widely used supplemental measures of operating and
financial performance of REITs, they should not be viewed as a
substitute measure of our operating performance since the measures
do not reflect either depreciation and amortization costs or the
level of capital expenditures and leasing costs necessary to
maintain the operating performance of our properties, which can be
significant economic costs that could materially impact our results
of operations. FFO and normalized FFO should not be considered an
alternative to net income (loss) (computed in accordance with GAAP)
as indicators of our financial performance or to cash flow from
operating activities (computed in accordance with GAAP) as an
indicator of our liquidity.
|
|
|
|
We calculate adjusted funds from operations, or AFFO, by subtracting
from or adding to normalized FFO (i) unbilled rent revenue, (ii)
non-cash share-based compensation expense, and (iii) amortization of
deferred financing costs. AFFO is an operating measurement that we
use to analyze our results of operations based on the receipt,
rather than the accrual, of our rental revenue and on certain other
adjustments. We believe that this is an important measurement
because our leases generally have significant contractual
escalations of base rents and therefore result in recognition of
rental income that is not collected until future periods, and costs
that are deferred or are non-cash charges. Our calculation of AFFO
may not be comparable to AFFO or similarly titled measures reported
by other REITs. AFFO should not be considered as an alternative to
net income (calculated pursuant to GAAP) as an indicator of our
results of operations or to cash flow from operating activities
(calculated pursuant to GAAP) as an indicator of our liquidity.
|
Source: Medical Properties Trust, Inc.
Medical Properties Trust, Inc.
Charles Lambert, 205-397-8897
Managing
Director – Capital Markets
clambert@medicalpropertiestrust.com